Código QR (código de barras bidimensional)

Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients

Background and Purpose: Tacrolimus (TAC) has been proven to be a rapid-acting, steroid-sparing agent for myasthenia gravis (MG) therapy. However, evidence related to the effectiveness of TAC alone is rare. Therefore, this study was performed to investigate the effect of TAC monotherapy in MG patient...

ver descrição completa

Na minha lista:
Principais autores: Zhirong Fan, Zunbo Li, Faxiu Shen, Xueping Zhang, Lin Lei, Shengyao Su, Yan Lu, Li Di, Min Wang, Min Xu, Yuwei Da
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020-10-01
coleção:Frontiers in Neurology
Assuntos:
myasthenia gravis
tacrolimus
monotherapy
clinical effectiveness
adverse events
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fneur.2020.594152/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados